Alkermes plc
ALKSNASDAQHealthcare● Active
$43.54
+$0.74(+1.72%)
Market Cap$7.3B
P/E Ratio—
52W High$43.69
52W Low$25.17
Alkermes plc (ALKS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ALKS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
-$0.40
Est. -$0.57 · +29.8%
Revenue
$0.39B
Est. $0.36B · +8.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
ALKS reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 28, 2026 | -$0.04 | — | — | — | $0.46B | — |
| ▲ Q2 FY2026 | May 5, 2026 | -$0.57 | -$0.40 | +29.8% | $0.39B | $0.36B | +8.2% |
| ▼ Q1 FY2026 | Feb 25, 2026 | $0.43 | $0.34 | -20.9% | $0.38B | $0.38B | +1.5% |
| ▲ Q4 FY2025 | Oct 28, 2025 | $0.42 | $0.49 | +16.7% | $0.39B | $0.38B | +3.8% |
| ▲ Q3 FY2025 | Jul 29, 2025 | $0.41 | $0.52 | +26.8% | $0.39B | $0.35B | +10.2% |
| ▼ Q2 FY2025 | May 1, 2025 | $0.25 | $0.13 | -48.9% | $0.31B | $0.30B | +1.2% |
| ▲ Q1 FY2025 | Feb 12, 2025 | $0.81 | $1.04 | +28.4% | $0.43B | $0.38B | +13.3% |
| ▼ Q4 FY2024 | Oct 24, 2024 | $0.74 | $0.72 | -2.7% | $0.38B | $0.38B | -0.8% |
Q3 FY2026
Jul 28, 2026
EPS Actual
—
EPS Est.
-$0.04
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
-$0.40
EPS Est.
-$0.57
EPS Surpr.
+29.8%
Revenue
$0.39B
Q1 FY2026
Feb 25, 2026Miss
EPS Actual
$0.34
EPS Est.
$0.43
EPS Surpr.
-20.9%
Revenue
$0.38B
Q4 FY2025
Oct 28, 2025Beat
EPS Actual
$0.49
EPS Est.
$0.42
EPS Surpr.
+16.7%
Revenue
$0.39B
Q3 FY2025
Jul 29, 2025Beat
EPS Actual
$0.52
EPS Est.
$0.41
EPS Surpr.
+26.8%
Revenue
$0.39B
Q2 FY2025
May 1, 2025Miss
EPS Actual
$0.13
EPS Est.
$0.25
EPS Surpr.
-48.9%
Revenue
$0.31B
Q1 FY2025
Feb 12, 2025Beat
EPS Actual
$1.04
EPS Est.
$0.81
EPS Surpr.
+28.4%
Revenue
$0.43B
Q4 FY2024
Oct 24, 2024Miss
EPS Actual
$0.72
EPS Est.
$0.74
EPS Surpr.
-2.7%
Revenue
$0.38B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.06 | $-0.06 | $-0.06 | 2 |
| Q3 FY2027 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Q2 FY2027 | $-0.04 | $-0.04 | $-0.03 | 1 |
| Q1 FY2027 | $-0.23 | $-0.22 | $-0.21 | 2 |
| Q4 FY2026 | $0.02 | $0.02 | $0.02 | 2 |
| Q3 FY2026 | $-0.04 | $0.01 | $0.04 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.5B | $0.5B | $0.5B | 5 |
| Q3 FY2027 | $0.4B | $0.5B | $0.5B | 5 |
| Q2 FY2027 | $0.4B | $0.5B | $0.5B | 5 |
| Q1 FY2027 | $0.4B | $0.4B | $0.5B | 5 |
| Q4 FY2026 | $0.5B | $0.5B | $0.5B | 5 |
| Q3 FY2026 | $0.5B | $0.5B | $0.5B | 10 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +29.8% | $34.17 | $36.25 | +6.09% |
| ▼ Q1 FY2026 | Feb 25, 2026 | -20.9% | $33.39 | $31.04 | -7.04% |
| ▲ Q4 FY2025 | Oct 28, 2025 | +16.7% | $29.72 | $31.00 | +4.31% |
| ▲ Q3 FY2025 | Jul 29, 2025 | +26.8% | $26.15 | $27.00 | +3.25% |
| ▼ Q2 FY2025 | May 1, 2025 | -48.9% | $28.77 | $30.58 | +6.29% |
| ▲ Q1 FY2025 | Feb 12, 2025 | +28.4% | $31.96 | $33.50 | +4.82% |
| ▼ Q4 FY2024 | Oct 24, 2024 | -2.7% | $27.85 | $26.85 | -3.59% |
| ▲ Q3 FY2024 | Jul 24, 2024 | +0.0% | $25.00 | $26.51 | +6.04% |
Q2 FY2026+6.09%
Report Date
May 5, 2026
EPS Beat/Miss
+29.8%
Price Before
$34.17
Price After
$36.25
Q1 FY2026-7.04%
Report Date
Feb 25, 2026
EPS Beat/Miss
-20.9%
Price Before
$33.39
Price After
$31.04
Q4 FY2025+4.31%
Report Date
Oct 28, 2025
EPS Beat/Miss
+16.7%
Price Before
$29.72
Price After
$31.00
Q3 FY2025+3.25%
Report Date
Jul 29, 2025
EPS Beat/Miss
+26.8%
Price Before
$26.15
Price After
$27.00
Q2 FY2025+6.29%
Report Date
May 1, 2025
EPS Beat/Miss
-48.9%
Price Before
$28.77
Price After
$30.58
Q1 FY2025+4.82%
Report Date
Feb 12, 2025
EPS Beat/Miss
+28.4%
Price Before
$31.96
Price After
$33.50
Q4 FY2024-3.59%
Report Date
Oct 24, 2024
EPS Beat/Miss
-2.7%
Price Before
$27.85
Price After
$26.85
Q3 FY2024+6.04%
Report Date
Jul 24, 2024
EPS Beat/Miss
+0.0%
Price Before
$25.00
Price After
$26.51
Avg Beat Reaction+4.90%
Avg Miss Reaction-1.45%
Beat Rate5 / 8 quarters
Largest Move-7.04% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ALKS ends December
Alkermes plc (ALKS) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $-0.40 — beating the analyst consensus of $-0.57 by +29.8%. The next ALKS earnings date is expected around September 1, 2026.
Each quarter, investors track ALKS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ALKS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ALKS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ALKS earnings · 5 questionsAlkermes plc's next earnings report is expected around September 1, 2026. ALKS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ALKS historically reports after market close (AMC).
ALKS earnings datewhen is ALKS earningsALKS next earnings datewhen does ALKS report earningsALKS earnings calendar
▸ Source: FMP · Alkermes plc SEC filings · US GAAP · Alkermes plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026